Unstable patients in shock trauma centers need decisive and immediate care. This CE offering focuses on two forms of treatment that can be used in your own trauma centers: molecular absorbent recirculating system (MARS) therapy for acute liver failure and resuscitative endovascular balloon occlusion of the aorta (REBOA) therapy. The topics begin with a detailed discussion of when MARS therapy and REBOA therapy are indicated in a patient so that you can feel confident that your patient will benefit from the treatment.
Upon conclusion of this presentation, you will be able to do the following:
- Recognize acute liver failure
- Describe and appropriate patient selection for MARS therapy
- Comprehend current indications and restrictions for REBOA catheters
- Know how to properly insert a REBOA catheter